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Background: Infections caused by Pseudomonas aeruginosa or Acinetobacter baumannii are of greatest concern for hospitalized patients, 
particularly those in intensive care units (ICUs). The aims of this study were to investigate the prevalence of integrons and biofilm formation 
among P. aeruginosa and A. baumannii isolates collected from ICU and non-ICU inpatients. 
Materials and Methods: A total of 90 P. aeruginosa and 90 A. baumannii isolates were recovered from patients admitted into diverse units 
of Shahid Mohammadi hospital in Bandar Abbas from January to December 2014. Bacterial identification was carried out by phenotypic 
methods and PCR. Antibiotic susceptibility was measured by disk diffusion assay. The presence of Class 1, 2, and 3 integrons were evaluated 
by multiplex-PCR. Biofilm quantification was done by microtiter method. 
Results: The highest number of isolates (48%) were recovered from ICU patients. 81% of P. aeruginosa isolates were sensitive to 
piperacillin/tazobactam and ticarcillin, while 60% were resistant to third generation of cephalosporins. In case of A. baumannii, all the isolates 
were sensitive to colistin, but 98% were resistant to other antibiotics (p≤0.05). Susceptibility to ceftazidime, ticarcillin, imipenem, and 
piperacillin/tazobactam were higher among isolates obtained from non-ICU patients. Class 1 integron was detected in 13.3% of the P. 
aeruginosa and 40% of the A. baumannii isolates, while Class 2 integron was harbored by 7 and 6.6% of the isolates, respectively. 
Furthermore, 23% of the A. baumannii and 12% of the P. aeruginosa isolates showed strong biofilm activity. 
Conclusion: Class 1 integron-positive isolates were resistant to three classes of antibiotics and predominantly observed in specimens 
collected from ICU patients showing strong biofilm. 
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1. Background 
Infections with P. aeruginosa and A. baumannii are of 
greatest concern for hospitalized patients, particularly those 
admitted into ICU, where these opportunistic pathogens are 
capable of causing severe invasive infections in patients with 
cystic fibrosis, neutropenia, iatrogenic immunosuppression, or 
severe burns (1, 2). Published data from the National 
Nosocomial Infections Surveillance (NNIS) System regarding 
intensive care unit (ICU) patients across the USA show that, in 
2003, Acinetobacter spp. were responsible for 6.9% of 
pneumonias, 2.4% of bloodstream infections, 2.1% of surgical 
site infections, and 1.6% of urinary tract infections, while 
Pseudomonas spp. were responsible for 18.1, 3.4, 9.5, and 
16.3% of these infections, respectively (3, 4). High level 
resistances to third generation of cephalosporins, quinolones, 
aminoglycosides, tetracycline, and chloramphenicol are 
widespread in clinical isolates of these two groups of bacteria, 
and treatment regimens for A. baumannii often rely on 
carbapenems and colistin and for P. aeruginosa often rely on 
piperacillin/tazobactam or ticarcillin (5). 
Although heterogeneous studies concluded that acquisition 
and spread of these microorganisms appeared to be related to a 
large number of variables. Among the most important 
variables were deficiencies in the implementation of infection 
control guidelines and the use of broad-spectrum antibiotics. 
The use of carbapenems and third-generation cephalosporins 
appeared to be related to the development of a multidrug  
 
 
resistance (MDR) phenotype by A. baumannii, while resistance 
to carbapenems and fluoroquinolones are implicated in MDR P. 
aeruginosa (6, 7). Several studies showed that integrons are 
associated with MDR in P. aeruginosa and A. baumannii 
isolates (7- 10). They are widely distributed among hospital 
pathogens and easily transferred to other species by conjugation 
or transposition. To date, four classes of integrons have been 
described in gram-negative bacterial isolates. Three main 
classes of integrons have a 5′ conserved segment, including an 
intI gene encoding an integrase and an attI recombination site 
but have distinct 3′ conserved segments (9). In the Class 1 
integrons, the 3′ conserved segment includes three open reading 
frames (ORFs)-qacEΔ1, a deletion derivative of the antiseptic 
resistance gene qacE; the sul1 sulfonamide resistance gene; and 
ORF5, of unknown function or int genes, as in Tn402 (10, 11). 
More than 80 different gene cassettes of Class 1 integrons have 
been described and shown to confer resistance to a wide range 
of antibiotics such as β-lactams, fluoroquinolones, 
aminoglycosides, chloramphenicol, trimethoprim, streptothricin, 
rifampin, erythromycin, fosfomycin, lincomycin, and 
antiseptics, and disinfectants (12). The second class of integrons 
(Class 2) was found in transposon Tn7 and its derivatives, and 
its 3′ conserved segment containing five tns genes involved in 
the movements of the transposon, which have been reported 
most often in isolates within the Enterobacteriaceae family (13). 
As compared to Class 1 and 2, less is known about Class 3 
integron which have been described as rare and found only in a 
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limited number of isolates including Serratia marcescens, 
Klebsiella pneumoniae, P. aeruginosa, P. putida, Alcaligenes 
xylosoxidans, and Delftia spp (14). Cassettes usually include a 
single ORF and downstream, an attC site which is an imperfect 
inverted repeat sequence related to a 60bp consensus sequence 
(14- 16). 
 There are few reports on the presence of integrons among 
hospital isolates of A. baumannii and P. aeruginosa in Iran.  In 
a study conducted in ICU of the Shahid Mohammadi hospital 
in Bandar Abas south of Iran, 39.4% of the P. aeruginosa 
isolates recovered from different places and devices, carried 
intI1 gene (17). No significant differences were seen between 
the presence of integron and resistance to the antibiotics 
except for ofloxacin. Similarly, of 63 nonduplicate A. 
baumannii isolates collected from clinical and environmental 
specimens in the Vali-Asr hospital in the central province of 
Iran, 98.4% carried a Class 1 integron. The prevalence of 
Class 2 integron was 15.9% (18). 
 
2. Objectives 
The aim of the current study was to evaluate the prevalence 
of Class 1, 2, 3 integrons and biofilm formation in drug-
resistant, colistin susceptible isolates of P. aeruginosa and A. 
baumannii in ICU and non-ICU patients of a teaching hospital 
in south of Iran. 
 
3. Materials and Methods  
3.1. Bacterial isolates and identification procedures  
A total of 90 isolates of each A. baumannii and P. 
aeruginosa were collected from patients hospitalized in different 
settings of the Shahid Mohammadi hospital in Bandar Abbas (a 
hospital with an excess of 450 beds) during the Year 2014. This 
hospital is the main referral treatment center in Hormozgan 
province, which admits all patients referring from other 
hospitals across the province. Also, this hospital is the most 
important center for admission patients with trauma, poisoning, 
and burn. Demographic information of the patients including 
length of stay in ICU, underlying diseases, age, gender, pervious 
surgery, length of stay during index hospitalization (mean) in 
the ICU and non-ICU inpatients, and previous antibiotic 
administration were studied. Samples (only one isolate per 
patient was included in the study) were collected by an expert 
laboratory technician, inoculated into 5 mL Stuart transport 
medium (Merck, Darmstadt- Germany), and transferred to the 
laboratory within 24 hr of the collections. First, Swab specimens 
were inoculated onto blood agar base with 5% sheep blood and 
MacConkey agar (Merck, Darmstadt-Germany) and incubated 
at 37°C for 18–24 hr. P. aeruginosa was isolated and identified 
from patients’ cultures by using routine bacteriological 
procedures including colony morphology, gram staining, 
pyocyanin pigment production, growth at 44°C, motility, 
catalase, oxidase tests, and ability to grow in citrimate agar. In 
case of A. baumannii, the isolates were inoculated into cysteine 
electrolyte deficient (CLED) agar (Hi-Media, India) and 
incubated at 37°C for 24 hr. Well isolated colonies then were 
subjected to fermentative/oxidative, motility, oxidase, and other 
conventional biochemical tests.  Final confirmation of A. 
baumannii species was performed by PCR using a set of primer 
specific for detection of blaOXA-51 gene. Prototype A. baumannii 
ATTC 19606 and P. aeruginosa ATCC 27853 were used as 
quality control strains through this study. 
 
3.2. Antibiotic susceptibility testing  
Antimicrobial susceptibility testing was performed at 37°C on 
Mueller-Hinton agar containing plates (Merck, Darmstadt- 
Germany) by using the Kirby-Bauer disk diffusion method on 
Mueller-Hinton agar plates according to the Clinical and 
Laboratory Standards Institute guidelines (CLSI) (19). All 
antibiotic disks were purchased from Mast Co. Ltd, UK and used 
as per manufacturer descriptions with an inoculum of 104 CFU 
per spot. Disks zone diameters were interpreted according to the 
CLSI recommendations for the chosen antibiotics and categorized 
according to the breakpoints for disk diffusion testing as sensitive, 
resistant or, intermediate. The following disks were used for 
antibiotic sensitivity (µg per disc); ceftazidime (CAZ, 30 µg), 
cefotaxime (CTX, 30 µg), ceftriaxone (CRO, 30 µg), cefepime 
(FEP, 30 µg), ticarcillin (TIC, 75 µg), piperacillin/tazobactam 
(PT, 100 µg), amikacin (AK, 30), gentamicin (GM, 10 µg), 
imipenem (IMP, 10 µg), meropenem (MEM, 10 µg), 
ciprofloxacin (CP, 5 µg), and doxycycline (D, 30 µg), and colistin 
(CL, 10 µg).  For straightforward result interpretations, 
intermediate resistant isolates were counted as resistant. E. coli 
ATCC 25922 and P. aeruginosa ATCC 27853 strains were 
simultaneously used as antibiotic sensitive control strains. 
 
3.3. Genomic DNA extraction 
All specimens were plated onto Luria- Bertani (LB) agar 
(BioMérieux, Marcy l'Etoile, France) and incubated at 37ºC 
for 24 hr. Genomic DNA was extracted from 90 isolates of P. 
aeruginosa and 90 isolates of A. baumannii by boiling method 
as described previously (20). Briefly, two well separated 
colonies of each isolate were dissolved in 200 µl of sterile 
D/W in 1.5 µl capacity Eppendorf tubes (Eppendorf, 
Germany) and placed in boiling water bath for 20 minutes. 
Cell lysates then were centrifuged for 7 minutes at 12.000 
rpm, and the supernatants were used for PCR reaction. The 
quality of the isolated DNA was measured by determination of 
absorbency at the wavelengths of A260 nm and A280 nm. 
 
3.4. Detection of Class 1, 2 and 3 integrons by 
multiplex-PCR 
All the isolates were screened for integrons Class 1, 2 and 3 
by using Multiplex –PCR technique. For detection, we used 
three sets of primers specific for the integrase intI1, intI2, and 
intI3. In addition, conserved sequence 5′ (CS) and 3′ (CS) 
regions of integrons were also amplified. The primers sequences 
and annealing temperatures used are shown in Table 1. The 
specificity of primers sequences were confirmed by the BLAST 
program, available at the NCBI homepage 
(http://www.ncbi.nlm.nih.gov/BLAST/). The reaction mixture 
was performed with a final volume of 25 µL. PCR Master Mix 
was consisted of 3µL 10X PCR buffer, 5µL of extracted DNA 
(20-50ng), 0.6 µL DNA Taq polymerase, 0.5 µL dNTPs Mix 
(10mM),  1.5  µL  (10  pM/µL)  of  each  primer  (forward  and  
reverse sequences), 0.8 µL 50 mM MgCl2, and 13.6 µL sterile 
D/W. DNA amplification was conducted in temperature 
gradient thermal cycler (Biometra-T300 gradient, Gottingen, 
Germany) with conditions as follows; initial DNA denaturation 
at 94⁰C for 10 minutes, followed by annealing temperatures of 
60⁰C (intI1), 58⁰C (intI2),  58°C (intI3), and 52⁰C (CS) for 40 
seconds,  with  an  extension  at  72⁰C  for  1  minute  and  a  final  
extension at 62°C for 10 minutes. K. pneumoniae ATCC1029 
containing the integron Classes 1 and 2 (kindly obtained from 
Pasteur Institute of Iran) was used as standard control strain. 
 
Integrons and biofilm in P. aeruginosa and A. baumannii 
 
Infect Epidemiol Med. 2016; Volume 2, Issue 4: 1-7. 3 
 
Table1. List of primers, sequences, sizes, and annealing temperatures used for the PCR amplification in this study. 
Target region Primer sequence (5´ → 3´) Size of product Annealing Temperature °C References 
intI-1F 
intI-1R 
CAGTGGACATAAGCCTGTTC 
CCCGAGGCATAGACTGTA 160bp 62 26 
intI-2F 
intI-2R 
GTAGCAAACGAGTGACGAAATG 
CACGGATATGCGACAAAAAGGT 788bp 62 27 
intI-3F 
intI-3R 
GCCTCCGGCAGCGACTTTCAG 
ACGGATCTGCCAAACCTGACT 979bp 62 28 
blaOXA-51F 
blaOXA-51R 
TAATGCTTTGATCGGCCTTG 
TGGATTGCACTTCATCTTGG 353bp 54 20 
Abbreviation: bp = base pair, F= forward sequence, R= reverse sequence  
 
3.5. Agarose gel electrophoresis 
Agarose  electrophoresis  was  performed  on  a  1%  W/V  
agarose gel in TBE buffer. The bands were visualized using a 
transilluminator. 
 
3.6. Biofilm quantification 
Biofilm quantification was carried out using crystal violet 
microtiter method as described previously (21). The isolates 
divided into strong, moderate, and weak biofilm producers based 
on cut-off optical density (ODc) of three standard deviations 
(SDs) above the mean of optical density of the negative control 
(contained broth only). If OD ≤ ODc, the bacteria were non-
adherent;  if  ODc  <  OD  ≤ 2  ×  ODc,  the  bacteria  were  weakly  
adherent;  if  2  ×  ODc  <  OD  ≤4  ×  ODc,  the  bacteria  were  
moderately adherent; if 4× ODc < OD, the isolates were strongly 
adherent. The results were performed in triplicate. P. aeruginosa 
PAO1 was considered as positive standard. 
 
3.7. Statistical analysis 
Statistical analysis was performed using SPSS 17.0 (SPSS, 
Chicago, IL, USA). Prevalence of MDR and integrons were 
compared using a chi-squared or Fisher’s exact test. Differences 
between the groups were analyzed using independent t-test. A 
probability value (p- value) within the range of 0.01-0.05 was 
considered to indicate statistical significance for two-tailed test. For 
descriptive statistics, we calculated percentage, frequency, mean, 
median values, and 95% confidence interval (95% CI). 
 
4. Results  
4.1. Characteristics of patients  
The patients admitted from January to December 2014 in 
different units of Shahid Mohammadi hospital, Bandar Abbas, 
were included in this study. The highest number of both P. 
aeruginosa (n= 40) and A. baumannii (n=  48)  isolates  were  
recovered from ICU patients, 24 isolates from medical ward 
(MW), and 14 isolates from burn unit, and remaining obtained 
from other units as shown in Fig. 1. The majority of ICU and burn 
patients had hospital stay ranged from 10 to 25 days with mean 
hospital stay of 15±0.2 Most of the patients were aged<35 years. 
40% of the patients were female and 60% were male. 
 
 
Figure 1. Prevalence of P. aeruginosa and A. baumannii in different 
hospital wards of Shahid Mohammadi hospital of Bandar Abbas, Iran.  
ICU = Intensive care unit, MW=Medical ward, BURN=Burn unit, 
EM=Emergency, OR=Operating room general surgery, NICU= 
Neonatal intensive care unit, CCU=Coronary care unit. 
4.2. Antimicrobial susceptibility of the isolates 
P. aeruginosa isolates were highly susceptible to colistin 
(100%), piperacillin/tazobactam (81.1%), and ticarcillin (75.5%), 
while they were resistant to third generation of cephalosporins (with 
average susceptibility rate of 30%) and doxycycline (48.6%), 
respectively (Table 2). In case of A. baumannii, all the isolates were 
susceptible to colistin and 23.3% to amikacin, but 98.8% were 
resistance to other antibiotics tested including imipenem, 
piperacillin/tazobactam, ticarcillin, cefepime, ceftazidime, 
ceftriaxone, cefotaxime, and ciprofloxacin. Interestingly, 25.5% of 
the isolates were sensitive to doxycycline (Table 2). The number of 
A. baumannii isolates exhibiting resistant to different classes of 
antibiotics, were more as compared to P. aeruginosa. (Table 3A). 
Seven isolates were resistant to more than three classes of antibiotics 
such as imipenem, piperacillin/tazobactam, cefepime, ceftazidime, 
ticarcillin, gentamicin, and ciprofloxacin except colistin to which 
nearly all Pseudomonas were sensitive. In this scheme, 13.3% of the 
isolates were resistant to three or more classes of the antibiotic 
belonging to the carbapenem groups; penicillins/cephalosporins, 
aminoglycosides, and quinolone were considered as MDR. The 
remaining isolates (86.7%) although were resistant to antibiotics but 
were not classified as MDR. In case of A. baumannii, 36 isolates 
were resistant to all antibiotics including carbapenems, 
cephalosporins, aminoglycosides, and ciprofloxacin but sensitive to 
colistin. In this regard, 24 isolates were resistant to 11 antibiotics, 
while 9 isolates were resistant to 10 antibiotics simultaneously. 
Antibiotic resistant patterns of the A. baumannii isolates are 
illustrated in Table 3B. In this scheme, 78.8% were considered as 
MDR. One isolate was found to be extensive drug resistance 
(XDR). Figure 2 shows the prevalence of MDR strains of P. 
aeruginosa and A. baumannii recovered from ICU patients and non-
ICU inpatients. The rate of changes in inhibition zone diameter of 
antibiotics in three different times (months) of collection, January, 
June, and December 2014, for A. baumannii isolates are 
demonstrated in Fig. 3. The results were expressed as the mean ± 
SD. There was no significant change in zone diameter during these 
periods. Similar results were obtained for P. aeruginosa isolates 
(data not shown). 
 
Figure 2. Frequency of multi-drug resistance (MDR) in P. 
aeruginosa and A. baumannii isolates recovered from ICU and non-
ICU inpatients. The results were expressed as the mean ± SD or as 
a proportion of the total number of patients or isolates. 
P. aeruginosa                A. baumannii 
N
um
be
r 
of
 is
ol
at
es
 
Hospital units 
Aryanezhad M et al. 
 
Infect Epidemiol Med. 2016; Volume 2, Issue 4: 1-7. 4 
 
 
 
Figure 3. Rate of changes in inhibition zone diameter of antibiotic in three different times (months) of collection. Jan, January; Jun, June; Dec, 
December 2014.The data are for A. baumannii isolates. The results were expressed as the mean ± SD. 
 
Table 2. Antibiotic susceptibility of P. aeruginosa and A. baumannii isolates recovered from patients in various setting of Mohammadi Bandar 
Abbas hospital, Iran. 
Antibiotic P. aeruginosa A. baumannii 
 
R 
N (%) 
I 
N (%) 
S 
N (%) 
R 
N (%) 
I 
N (%) 
S 
N (%) 
IMP 27(30) 3(3.3) 60(66.6) 80(88.8) 7(7.7) 3(3.3) 
PT 17(18.8) 0(0.0) 73(81.1) 87(96.6) 2(2.2) 1(1.1) 
TIC 16(17.7) 6(6.6) 68(75.5) 88(97.7) 2(2.2) 0(0.0) 
FEP 35(38.8) 7(7.7) 48(53.3) 89(98.8) 0(0.0) 1(1.1) 
CAZ 44(48.8) 11(12.2) 35(38.8) 89(98.8) 0(0.0) 1(1.1) 
CRO 54(60) 16(17.7) 20(22.2) 89(98.8) 0(0.0) 1(1.1) 
CTX 48(53.3) 15(16.6) 27(30) 90(100) 0(0.0) 0(0.0) 
GM 23(25.5) 9(10) 58(64.4) 79(87.7) 4(4.4) 7(7.7) 
AK 21(23.3) 10(11.1) 59(65.5) 65(72.2) 4(4.4) 21(23.3) 
CP 22(19.8) 8(7.2) 60(54) 89(98.8) 0(0.0) 1(1.1) 
D 54(48.6) 16(17.8) 20(22.2) 60(66.6) 7(7.7) 23(25.5) 
CL 0(0.0) 0(0.0) 90(100) 0(0.0) 0(0.0) 90(100) 
Abbreviations; IMP, imipenem; PT, piperacillin/tazobactam; TIC, ticarcillin; FEP, cefepime; CAZ, ceftazidime; CRO, ceftriaxone; CTX, 
cefotaxime; GM, gentamicin; AK, amikacin; CP, ciprofloxacin; D, doxycycline; CL, colistin. 
 
Table 3. Antibiotic resistant patterns, possession of integron classes and hospital unit involved of A) P. aeruginosa and B) A. baumannii 
isolates recovered from hospitalized patient in Shahid Mohammadi hospital in Bandar Abbas, south of Iran. 
 
A) 
Antibiotic resistance pattern No. of isolates No. of antibiotics 
Presence of integron 
classes 
Hospital 
unit P-value 
IMP-PT-FEP-CAZ-TIC-GM-CP 12 7 1 ICU 0.215 
IMP -FEP-CAZ-TIC-GM 7 5 1 ICU 0.319 
IMP -PT-FEP-CAZ-GM 2 5 1 burn 0.314 
IMP -PT-FEP-CAZ-TIC 2 5 - EM 0.323 
IMP -FEP-CAZ-GM 2 4 - NICU 0.148 
FEP-CAZ-TIC-GM 1 4 - burn 0.314 
IMP -CAZ-TIC-GM 1 4 - OR 0.223 
IMP -FEP-CAZ-TIC 1 4 - CCU 0.321 
PT-FEP-TIC-GM 1 4 - others 0.314 
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B) 
Antibiotic resistance pattern No. of isolates 
No. of 
antibiotic 
Presence of 
integron 
classes 
Hospital 
unit P-value 
IMP-MEM-PT-TC-FEP-CRO-CAZ-CP-D-CTX-GM-AK 36 12 1 ICU 0.221 
IMP -MEM-PT-TC-FEP-CRO-CAZ-CP-CTX-GM-AK 24 11 1 ICU 0.358 
IMP -MEM-PT-TC-FEP-CRO-CAZ-CP-D-CTX-GM 9 11 1 burn 0.325 
MEM-PT-TIC-FEP-CRO-CAZ-CP-D-CTX-GM-AK 1 11 1 NICU 0.311 
IMP -MEM-PT-TC-FEP-CRO-CAZ-CP-D-CTX-AK 1 11 1 Burn 0.131 
IMP -MEM-PT-TC-FEP-CRO-CAZ-CP-D-CTX 9 10 1 Surgery 0.371 
MEM-PT-TC-FEP-CRO-CAZ-CP-CTX-GM-AK 3 10 1 OR 0.200 
MEM-PT-TC-FEP-CRO-CAZ-CP-D-CTX-GM 2 10 1 MW 0.300 
MEM-PT-TC-FEP-CRO-CAZ-CP-CTX-GM 1 9 1 EM 0.378 
MEM-PT-FEP-CRO-CAZ-CP-D-CTX-GM 1 9 - others 0.300 
IMP -MEM-TC-FEP-CRO-CAZ-CP-CTX-GM 1 9 - surgery 0.172 
MEM-FEP-CRO-CAZ-CP-D-CTX-GM 1 8 - others 0.321 
The χ2 test or Fisher's exact test was used to compare proportions. Statistical significance (p) was calculated using the Pearson Chi-square test in 
terms of the number of resistant strains and susceptible strains. Intermediate isolates were considered as nonsusceptible isolates. All tests of 
significance are 2-tailed; p- value was set at range from 0.1 to 0.5. 
 
4.3. Biofilm formation among isolates collected from 
ICU and non-ICU patients 
We studied and compared the number of isolates exhibiting 
strong biofilm in both A. baumannii and P. aeruginosa isolates 
(Fig. 4). Interestingly, we observed that the number of isolates 
showing strong biofilm in ICU, was higher than non-ICU 
isolates; moreover, the number of A. baumannii isolates 
forming strong biofilm, was more as compared to P. 
aeruginosa both in ICU and non-ICU patients. The results 
were repeated at least three times, and similar observations 
were obtained.  
 
 
Figure 4. Number of isolates showing positive biofilm collected from 
patients admitted in ICU and non-ICU. The above results are mean of 
at least three independent experiments. P≤0.05 was considered 
statistically significant. 
 
4.4. Prevalence of Class 1, 2 and 3 integrons 
Evaluation of integrons classes by multiplex–PCR based 
method revealed that 13.3 and 7% of the P. aeruginosa 
isolates carried integron Class 1 and 2, while this rate for A. 
baumannii isolates were 40 and 6.6%, respectively. In general, 
the frequency of the isolates carried Class 1 integron was 
higher in case of ICU patients as compare with non-ICU 
inpatients in both cases (Table 3A and B). Integron Class 1 
was also detected in isolates obtained from burn patients or 
those who had surgery. We did not detect integron Class 3 in 
any of the isolates of both the cases. The agarose gel 
electrophoresis of PCR products for integrons Classes 1 and 2 
in P. aeruginosa and A. baumannii isolates are illustrated in 
Fig. 5A and Fig. 5B, respectively. Integron Class 1 positive 
isolates were statistically more resistant to at least three 
classes of antibiotics. The chi-square test was used to calculate 
the P-value in terms of resistant, intermediate, and susceptible 
numbers of integron-positive and integron-negative isolates (2 
degrees of freedom). Integrons were significantly associated 
with resistance to certain antibiotics, including aminoglyc-
osides, quinolones, and beta-lactam agents in both types of 
isolates. Nevertheless, no correlation was observed between 
the presence of integron Class 2 and multi-resistance 
properties of the isolates in both cases (p≤0.05). 
 
A) 
 
B) 
 
 
Figure 5. Agarose gel electrophoresis of PCR product of the Class 1 
and 2 integrons extracted from A) P. aeruginosa and B) A. 
baumannii isolates. 
Electrophoresis was conducted in 1% agarose gel and the gel 
was stained with tracking dye for 5-10 min. The PCR products 
were then observed under UV. Gel documentation system. 
 
5. Discussion 
Recent clinical attention has focused on the increasing 
frequency of nonlactose fermenting gram-negative pathogens 
responsible for hospital-acquired infections. In this group, 
Acinetobacter species and P. aeruginosa are emerging as 
pathogens that frequently cause infections in patients with 
high sever consequences in intensive care units (22). Several 
investigators have studied various aspects of these infections 
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including mechanisms and risk factors of development of 
resistance as well as the effectiveness and toxicity of various 
therapeutic options. In multivariate analysis, the strongest risk 
factors for hospital-acquired infections acquired in ICU were 
intubation, urinary catheter, severity of illness, involvement of 
a family member in patient care, and surgery after admission 
(23). 
The dissemination of antibiotic resistance genes between 
bacteria leads to serious problems in the treatment of 
infectious diseases. It has been shown that resistance genes 
can be carried by the integrons. There are limited studies 
carried out regarding the carriage rate of Class 1 and 2 
integrons in A. baumannii and P. aeruginosa clinical strains in 
Iran. 
In the present study we found that the majority of P. 
aeruginosa isolates were resistant to several antibiotics. 
Susceptibility to ceftazidime, ticarcillin, imipenem, and 
piperacillin/tazobactam was higher among isolates from non-
ICU inpatients than among isolates from ICU patients. The 
rate of resistance based on number in population was quite 
higher in case of A. baumannii as compared to P. aeruginosa 
isolates. The majority of A. baumannii isolates were resistant 
to all antibiotic tested except colistin, and at least one isolate 
was extensive drug resistance. In our study, 70% of the 
isolates showed pattern of resistance to 12 antibiotics 
simultaneously, in compare, 7.7% of the P. aeruginosa ICU 
isolates were resistant to six antibiotics, but many were 
sensitive to piperacillin/tazobactam, imipenem, amikacin, and 
ticarcillin. The results suggested that colistin could be the drug 
of choice for treatment of A. baumannii, and the reason for 
susceptibility of all the isolates to colistin may rely on the 
absence of this antibiotic in routine treatments of inpatients in 
Shahid Mohammadi hospital. Similarly, 
piperacillin/tazobactam and ticarcillin antibiotics are used for 
treatment of neutropenic patients infected with P. aeruginosa. 
In order to see the change in susceptibility of the isolates over 
the course of time, we compared antibiotic sensitivity tests of 
bacterial samples in January, June, and December. We did not 
find  any  differences  in  zone  diameter  in  this  period  of  time  
among the isolates. 
In a study, it has been reported that patients with 
Escherichia coli or Klebsiella species were more likely to 
receive inappropriate empiric therapy. In this study, all the 
ESBL-negative patients were appropriately treated at some 
point during their antimicrobial course. However, a total of 
8% (six out of 75) of the cases failed to receive effective 
antibiotics at any time during their course of therapy (23). 
Similar cases may be true for patients infected with A. 
baumannii and P. aeruginosa in our case. 
In another study carried out in Turkey, a total of 137 strains 
(77 A. baumannii and 60 P. aeruginosa)  were  isolated  from  
various clinical specimens, the highest susceptibility rates 
were found against colistin (96%) and tigecycline (78%) in A. 
baumannii, and against piperacillin/tazobactam (97%) and 
piperacillin (93%) in P. aeruginosa isolates. The highest 
resistance rate was determined against piperacillin/tazobactam 
(95%) in A. baumannii strains (24).  
Gu et al. reported isolation of 98 P. aeruginosa isolates and 
106 Acinetobacter sp. from four general hospitals in the Nanjing 
area of China. P. aeruginosa strains were resistant to antibiotics 
including cefotaxime, trimethoprim-sulfamethoxazole, tetracy-
cline, and chloramphenicol.  In case of A. baumannii, the 
isolates were resistant to piperacillin, cefotaxime, ceftazidime, 
cefepime, aztreonam, norfloxacin, trimethoprim-sulfameth-
oxazole, tetracycline, and chloramphenicol (25). 
We also studied the presence of three different integrons 
among hospital isolates of P. aeruginosa and A. baumannii. 
Interestingly, the prevalence of integron Class 1 in both 
microorganisms was higher as compared to integron Class 2. 
Moreover, there was a significant correlation between 
resistance patterns of the isolates and the presence of integron 
Class 1among ICU patients as compare with non-ICU patients. 
The results suggest that resistance to third generation of 
cephalosporins, carbapenems, aminoglycosides, and 
aminopenicillins may be resided, as gene cassettes, on 
integron Class 1, and clonal spread of these resistance genes 
among patient populations in different hospital setting, 
particularly  in  ICU,  may  also  be  the  reason  for  MDR  
phenotypes. We also found that as length of stay in ICU 
increases for per patient, there is a higher chance to be 
colonized with MDR isolates of A. baumannii or P. 
aeruginosa carrying integron Class 1. In this regard, we found 
the 13% increase in colonization by A. baumannii in patients 
with length of stay more than 15 days. In addition, biofilm 
formation assay showed considerable number of both A. 
baumannii and P. aeruginosa isolates exhibiting strong 
biofilm from specimen collected from ICU patients than non-
ICU inpatients. This indicates that ICU isolates were more 
virulent that non-ICU isolates since biofilm formation is 
associated with increase in virulence capacity of the organism 
as well. The results also suggest that antibiotic resistance in 
non-integron-encoding isolates may probably be due to 
biofilm formation. 
A total of 189 A. baumannii isolates were collected in 2011 
from a teaching hospital in Chongqing, China (26). Among 
which, 144 isolates (76.2%) were found to have the integron 
cassette, which was absent in the rest. Among the integron-
positive isolates, 136 of the isolates had a Class 1 integron 
cassette, and eight had a Class 2 integron cassette. None of the 
isolates was found to encode Class 3 integrons. In another 
study, Nikokar et al. (27) reported that 37 (43%) P. 
aeruginosa isolates and 27 (69.2%) MDR strains harbored 
Class 1 integron in a burn center.  
 
6. Conclusion 
Acquisition of antibiotic-resistant ICU bacteria depends on 
ICU-related variables (nurse-to-patient ratios, compliance with 
hand hygiene) and patient-related factors (severity of illness, 
prior hospitalization, invasive procedures, antibiotic use). 
Present investigation showed the emergence of MDR among 
A. baumannii isolates in different units of hospital.  The 
existence of Class 1 and 2 integrons might be responsible for 
spread and dissemination of antibiotic resistance genes among 
bacterial population, especially in ICU. Our findings also 
highlight the emerging challenges that Acinetobacter species 
pose to health care facilities. Further research must be carried 
out for molecular typing of these isolates. 
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